|Bid||0.00 x 1000|
|Ask||0.00 x 2900|
|Day's Range||17.10 - 18.77|
|52 Week Range||17.10 - 47.84|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Nurix Therapeutics, Inc. (NRIX) delivered earnings and revenue surprises of -26.87% and 50.67%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
The nature of investing is that you win some, and you lose some. Anyone who held Nurix Therapeutics, Inc. ( NASDAQ:NRIX...
Investment company Mass General Brigham, Inc (Current Portfolio) buys DocuSign Inc, Oyster Point Pharma Inc, Dada Nexus, Airbnb Inc, sells iShares Core S&P 500 ETF, iShares Core U.S.